SANOGENE THERAPEUTICS
SanoGene Therapeutics is a biotechnology company that develops biopharmaceutical.
SANOGENE THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Status:
Active
Similar Organizations
Ascenion GmbH
Ascenion GmbH is a biotechnology company that also manufactures pharmaceuticals.
BioInVision
BioInVision is a biotechnology firm that detects fluorescently labeled stem or cancer cells.
Corino Therapeutics
Corino Therapeutics is a private, development-stage biopharmaceutical company
Exeter Antioxidant Therapeutics Ltd.
Exeter Antioxidant Therapeutics Ltd. is a young, dynamic company established to further the development of therapeutic catalysts.
Lionex Diagnostics & Therapeutics
Lionex Diagnostics & Therapeutics is a German biotech company active in the fields of biomedicine and human health
Marijuana Genetics
Marijuana Genetics is all about whole plant therapy for physical, emotional and spiritual protection.
Schedule 1 Therapeutics
Schedule 1 Therapeutics is a preclinical stage biopharmaceutical company that develops cannabis-based medicines.
Syngen Research
Syngen Research is a biotechnology company that provides research on synthetic nucleic acids.
Tactile Therapeutics
Tactile Therapeutics is a biotechnology company that serves the life science industry.
Founder
More informations about "SanoGene Therapeutics"
SanoGene Therapeutics - Drug pipelines, Patents, Clinical trials
Last update 02 May 2024. SanoGene Therapeutics. Private Company |See details»
SanoGene Theraputics Company Profile 2024: Valuation, Funding ...
Nov 19, 2017 SanoGene Theraputics General Information Description. Developer of biopharmaceutical products designed to prevent deadly cancers. The company's …See details»
Cancer cure company wins business plan challenge - CNET
Mar 28, 2006 The $10,000 prize is a token compared with the millions the winning company, SanoGene Therapeutics, will need to launch human drug trials before releasing a cure …See details»
SanoGene Therapeutics Inc Company Profile, Financial and
SanoGene Therapeutics Inc., an early stage biotechnology company, utilizing RNA interference (RNAi) technology to develop biopharmaceutical products for incurable cancers. The company …See details»
Caralynn Nowinski | Crain's Chicago Business
30 Associate, Midwest Venture Partners; president, SanoGene Therapeutics Inc. Caralynn Nowinski turned a class project into a career. In 2006, while on hiatus from medical school to …See details»
RNAi Startup SanoGene Moves Brain Cancer Drug into IND
May 28, 2009 SanoGene core technology is an expressed RNAi approach developed in the lab of cancer researcher Jasti Rao at the University of Illinois College of Medicine at Peoria. Rao, …See details»
SanoGene Therapeutics - Crunchbase
Organization. SanoGene Therapeutics . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. Companies …See details»
SanoGene Therapeutics Inc.
Oct 1, 2007 SanoGene Therapeutics thinks it will be able to enhance outcomes for glioblastoma patients by following the unavoidable brain surgery with an injection of targeted plasmids …See details»
Nextsource | Company Profile | SanoGene Therapeutics
See how SanoGene Therapeutics is performing against competitors in their latest market positioning. Find out if SanoGene Therapeutics has recently secured any major clients or …See details»
Home - Allogene
REDEFINING THE FUTURE OF CELL THERAPY WITH OUR AlloCAR Tâ„¢ PRODUCT PLATFORM INNOVATION Multiplex gene-engineering and gene-editing capabilities …See details»
Pephexia Therapeutics - Crunchbase
Pephexia Therapeutics, Mannin Research, Elevated Life Sciences, and SanoGene Therapeutics are all part of the biotechnology sector. Pephexia and Mannin Research focus on …See details»
The current landscape of nucleic acid therapeutics - Nature
May 31, 2021 The increasing number of approved nucleic acid therapeutics demonstrates the potential to treat diseases by targeting their genetic blueprints in vivo. Conventional treatments …See details»
Onasemnogene abeparvovec gene replacement therapy for the
May 24, 2022 Spinal muscular atrophy (SMA) is a genetically inherited recessive neuromuscular disease caused by mutations in the survival motor neuron 1 (SMN1) gene [] located in the …See details»
Jupiter BioVentures - Crunchbase
Organization. Jupiter BioVentures . Connect to CRM . Save . Summary. People. Technology. Signals & News. ... SanoGene Therapeutics is a biotechnology company that develops …See details»
NIH, FDA and 15 private organizations join forces to increase …
The FNIH works with its partners to accelerate biomedical research and strategies against diseases and health concerns in the United States and across the globe. Established by …See details»
Apogee Therapeutics | Best-in-Class Therapies for Immunological …
Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), …See details»
Fate Therapeutics Announces Leadership Transition
Under his direction, the Company has established a world class R&D organization yielding numerous high-tier journal publications, over 500 issued patents, and a pipeline of highly …See details»
Juvenor Pharmaceuticals - Crunchbase
Organization. Juvenor Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Similar Companies. ... SanoGene …See details»
PTC Therapeutics signs up to $2.9 billion licensing deal with ... - MSN
(Reuters) - PTC Therapeutics has signed an up to $2.9 billion licensing deal with Novartis AG for the U.S. company's experimental drug for a rare neurological disorder, sending its shares up …See details»